Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Reexamination Certificate
2006-05-09
2006-05-09
Kim, Vickie (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
C514S729000, C514S741000
Reexamination Certificate
active
07041704
ABSTRACT:
The invention relates to methods of using sodium channel modulators, particularly TTX-R sodium channel modulators and/or activity dependent sodium channel modulators to treat a gastrointestinal tract disorders, particularly inflammatory bowel disorders and irritable bowel syndrome.
REFERENCES:
patent: 5331013 (1994-07-01), Ahlman et al.
patent: 6124308 (2000-09-01), Nobbs et al.
patent: 6265405 (2001-07-01), Cox et al.
patent: 6355637 (2002-03-01), Axt et al.
patent: 6576669 (2003-06-01), Anderskewitz et al.
patent: 6821739 (2004-11-01), Braun et al.
patent: 2003/0036070 (2003-02-01), Chakravarti
patent: 0 400 495 (1990-05-01), None
patent: WO 98/38174 (1998-09-01), None
patent: WO 01/45684 (2001-06-01), None
Cintron, L.M., et al., “Neuropathic Agents for Treating Chronic Visceral Pain,”Society for neuroscience Abstracts, 2001, p. 927 vol. 27(1).
Holzer, P., “Gastrointestinal Afferents as Targets of Novel Drugs for the Treatment of Functional Bowel Disorders and Visceral Pain,”European Journal of Pharmacology, 2001, pp. 177-193, vol. 429(1-3).
Pevarello, P., et al., “synthesis and Anticonvulsant Activity of a New Class of 2-[(Arylalkyl)amino] alkanamide Derivatives,”Journal of Medicinal Chemistry, 1998, pp. 579-590, vol. 41(4).
Scholz, A., et al., “Complex Blockade of TTX-Resistant Na+ Currents by Lodocaine and Bupivacaine Reduce Firing Frequence in DRG Neurons,”Journal of Neurophysiology, 1998, pp. 1746-1754, vol. 79(4).
Burgard Edward C.
Fraser Matthew Oliver
Landau Steven B.
Alston & Bird LLP
Dynogen Pharmaceuticals, Inc.
Kim Vickie
LandOfFree
Methods of treating gastrointestinal tract disorders using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating gastrointestinal tract disorders using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating gastrointestinal tract disorders using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3549354